The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies

The crosstalk between the tumour immune microenvironment (TIME) and tumour cells promote immune evasion and resistance to immunotherapy in gastrointestinal (GI) tumours. Post-transcriptional regulation of genes is pivotal to GI tumours progression, and RNA-binding proteins (RBPs) serve as key regula...

Full description

Saved in:
Bibliographic Details
Main Authors: Dongqi Li, Xiangyu Chu, Weikang Liu, Yongsu Ma, Xiaodong Tian, Yinmo Yang
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:RNA Biology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/15476286.2024.2440683
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841554882589360128
author Dongqi Li
Xiangyu Chu
Weikang Liu
Yongsu Ma
Xiaodong Tian
Yinmo Yang
author_facet Dongqi Li
Xiangyu Chu
Weikang Liu
Yongsu Ma
Xiaodong Tian
Yinmo Yang
author_sort Dongqi Li
collection DOAJ
description The crosstalk between the tumour immune microenvironment (TIME) and tumour cells promote immune evasion and resistance to immunotherapy in gastrointestinal (GI) tumours. Post-transcriptional regulation of genes is pivotal to GI tumours progression, and RNA-binding proteins (RBPs) serve as key regulators via their RNA-binding domains. RBPs may exhibit either anti-tumour or pro-tumour functions by influencing the TIME through the modulation of mRNAs and non-coding RNAs expression, as well as post-transcriptional modifications, primarily N6-methyladenosine (m6A). Aberrant regulation of RBPs, such as HuR and YBX1, typically enhances tumour immune escape and impacts prognosis of GI tumour patients. Further, while targeting RBPs offers a promising strategy for improving immunotherapy in GI cancers, the mechanisms by which RBPs regulate the TIME in these tumours remain poorly understood, and the therapeutic application is still in its early stages. This review summarizes current advances in exploring the roles of RBPs in regulating genes expression and their effect on the TIME of GI tumours, then providing theoretical insights for RBP-targeted cancer therapies.
format Article
id doaj-art-a096ab3cadae48c6bfb921142e7b5bf1
institution Kabale University
issn 1547-6286
1555-8584
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series RNA Biology
spelling doaj-art-a096ab3cadae48c6bfb921142e7b5bf12025-01-08T08:54:39ZengTaylor & Francis GroupRNA Biology1547-62861555-85842025-12-0122111410.1080/15476286.2024.2440683The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignanciesDongqi Li0Xiangyu Chu1Weikang Liu2Yongsu Ma3Xiaodong Tian4Yinmo Yang5Department of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, Beijing, ChinaDepartment of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaDepartment of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, Beijing, ChinaDepartment of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, Beijing, ChinaDepartment of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, Beijing, ChinaDepartment of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, Beijing, ChinaThe crosstalk between the tumour immune microenvironment (TIME) and tumour cells promote immune evasion and resistance to immunotherapy in gastrointestinal (GI) tumours. Post-transcriptional regulation of genes is pivotal to GI tumours progression, and RNA-binding proteins (RBPs) serve as key regulators via their RNA-binding domains. RBPs may exhibit either anti-tumour or pro-tumour functions by influencing the TIME through the modulation of mRNAs and non-coding RNAs expression, as well as post-transcriptional modifications, primarily N6-methyladenosine (m6A). Aberrant regulation of RBPs, such as HuR and YBX1, typically enhances tumour immune escape and impacts prognosis of GI tumour patients. Further, while targeting RBPs offers a promising strategy for improving immunotherapy in GI cancers, the mechanisms by which RBPs regulate the TIME in these tumours remain poorly understood, and the therapeutic application is still in its early stages. This review summarizes current advances in exploring the roles of RBPs in regulating genes expression and their effect on the TIME of GI tumours, then providing theoretical insights for RBP-targeted cancer therapies.https://www.tandfonline.com/doi/10.1080/15476286.2024.2440683RNA binding proteinmRNAsncRNAstumour immune microenvironmentimmunotherapytargeted therapy
spellingShingle Dongqi Li
Xiangyu Chu
Weikang Liu
Yongsu Ma
Xiaodong Tian
Yinmo Yang
The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies
RNA Biology
RNA binding protein
mRNAs
ncRNAs
tumour immune microenvironment
immunotherapy
targeted therapy
title The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies
title_full The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies
title_fullStr The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies
title_full_unstemmed The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies
title_short The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies
title_sort regulatory roles of rna binding proteins in the tumour immune microenvironment of gastrointestinal malignancies
topic RNA binding protein
mRNAs
ncRNAs
tumour immune microenvironment
immunotherapy
targeted therapy
url https://www.tandfonline.com/doi/10.1080/15476286.2024.2440683
work_keys_str_mv AT dongqili theregulatoryrolesofrnabindingproteinsinthetumourimmunemicroenvironmentofgastrointestinalmalignancies
AT xiangyuchu theregulatoryrolesofrnabindingproteinsinthetumourimmunemicroenvironmentofgastrointestinalmalignancies
AT weikangliu theregulatoryrolesofrnabindingproteinsinthetumourimmunemicroenvironmentofgastrointestinalmalignancies
AT yongsuma theregulatoryrolesofrnabindingproteinsinthetumourimmunemicroenvironmentofgastrointestinalmalignancies
AT xiaodongtian theregulatoryrolesofrnabindingproteinsinthetumourimmunemicroenvironmentofgastrointestinalmalignancies
AT yinmoyang theregulatoryrolesofrnabindingproteinsinthetumourimmunemicroenvironmentofgastrointestinalmalignancies
AT dongqili regulatoryrolesofrnabindingproteinsinthetumourimmunemicroenvironmentofgastrointestinalmalignancies
AT xiangyuchu regulatoryrolesofrnabindingproteinsinthetumourimmunemicroenvironmentofgastrointestinalmalignancies
AT weikangliu regulatoryrolesofrnabindingproteinsinthetumourimmunemicroenvironmentofgastrointestinalmalignancies
AT yongsuma regulatoryrolesofrnabindingproteinsinthetumourimmunemicroenvironmentofgastrointestinalmalignancies
AT xiaodongtian regulatoryrolesofrnabindingproteinsinthetumourimmunemicroenvironmentofgastrointestinalmalignancies
AT yinmoyang regulatoryrolesofrnabindingproteinsinthetumourimmunemicroenvironmentofgastrointestinalmalignancies